Korea Investment & Securities lowers Humedics target price by 25%...intensifying competition in Chinese market
Korea Investment & Securities lowered its target price for Humedics by 25% to 45,000 won, citing a downgrade in earnings outlook. This adjustment reflects a weakening investment sentiment in the overall bio/healthcare sector and concerns about slowing profitability, particularly in the filler segment, due to intensified competition in the Chinese market.
Key takeaway
"Korea Investment & Securities lowers Humedics target price by 25%...intensifying competition in Chinese market" — BullBear's AI rates this story as a bearish (negative) signal for markets, with a market-impact score of 55 out of 100. Korea Investment & Securities lowered its target price for Humedics by 25% to 45,000 won, citing a downgrade in earnings outlook. This adjustment reflects a weakening investment sentiment in the overall bio/healthcare sector and concerns about slowing profitability, particularly in the filler segment, due to intensified competition in the Chinese market. Reported by TokenPost on June 29, 2026. The call is verified against the actual 24-hour price move on BullBear's public conviction ledger.
Catch the next bear flag
Telegram alerts when our AI scores a story 80+/100 impact (~1-3 per day, no spam). Verified 30d hit rate 53.1%.